StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) income statement

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$13.62+0.77 (+5.99%)

Close on Nov 18, 2026Market cap $182.28MP/E –Yield –

Anika Therapeutics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
62.2%
Operating margin
-4.2%
Net margin
-3.1%
Return on equity, FY2025
-7.3%

Financial strength

Current ratio
4.48
Debt to equity
–
Debt to assets
–
Cash to current liabilities
173.4%

Valuation

P/E ratio
–
Price to sales
1.51
Price to book
1.33
Dividend yield
–

See a number that looks wrong?